CH478820A - Process for the production of new piperidine derivatives - Google Patents

Process for the production of new piperidine derivatives

Info

Publication number
CH478820A
CH478820A CH53669A CH5366966A CH478820A CH 478820 A CH478820 A CH 478820A CH 53669 A CH53669 A CH 53669A CH 5366966 A CH5366966 A CH 5366966A CH 478820 A CH478820 A CH 478820A
Authority
CH
Switzerland
Prior art keywords
piperidine
oxo
hydroxy
pyrrolidinyl
benzyl
Prior art date
Application number
CH53669A
Other languages
German (de)
Inventor
Ernst Dr Jucker
Anton Dr Ebnoether
Erwin Dr Rissi
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH53669A priority Critical patent/CH478820A/en
Priority claimed from CH679966A external-priority patent/CH480363A/en
Priority claimed from CH708166A external-priority patent/CH476757A/en
Priority claimed from CH337167A external-priority patent/CH504467A/en
Publication of CH478820A publication Critical patent/CH478820A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Description

  

  



  Verfahren zur Herstellung neuer Piperidin-Derivate
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen   Piperidin-Derivaten    der Formel I, worin R für eine niedere Alkylgruppe steht.



   Erfindungsgemäss werden die Verbindungen der Formel I hergestellt, indem man Verbindungen der Formel II, worin R obige Bedeutung besitzt, in Gegenwart eines Alkalimetallamids in einem unter den Reaktionsbedingungen inerten Lösungsmittel, mit   l-Benzyl-    4-piperidon umsetzt und von dem erhaltenen Kondensationsprodukt die Benzylgruppe hydrogenolytisch abspaltet.



   Bei dem erfindungsgemässen Verfahren wird als Alkalimetallamid vorzugsweise Lithiumamid, als unter den Reaktionsbedingungen inertes Lösungsmittel, z. B. flüssiger Ammoniak, absoluter Äther, absolutes Dioxan oder deren Gemische verwendet.



   Das Verfahren wird beispielsweise so durchgeführt, dass man eine Suspension von Lithiumamid in flüssigem Ammoniak langsam mit der Verbindung der Formel II versetzt und nach etwa 30 Minuten Rühren l-Benzyl-4piperidon tropfenweise zugibt. Nach etwa 2stündigem Rühren lässt man den Ammoniak verdampfen, versetzt den Rückstand mit abs. Äther und rührt das Gemisch zur Vervollständigung der Reaktion während 4-5 Stunden. bei Siedetemperatur des Lösungsmittels. Anschlie ssend wird das Reaktionsgemisch unter Kühlen mit wässriger Ammoniumchloridlösung zersetzt; die Ätherphase wird mit Wasser gewaschen, getrocknet und eingedampft.



   Zur hydrogenolytischen Abspaltung der Benzylgruppe wird die als Rückstand erhaltene Verbindung, z. B. in Eisessig, über einem Palladiumkatalysator bei etwa 500 und etwa 5 atü in einem Druckgefäss hydriert.



   Die erfindungsgemäss hergestellten Verbindungen der Formel I sind bisher nicht beschrieben. Sie sind Zwischenprodukte für wertvolle Arzneimittel.



   In den nachfolgenden Beispielen, welche die Durchführung des Verfahrens erläutern, den Umfang der vorliegenden Erfindung aber in keiner Weise einschränken sollen, erfolgen alle Temperaturangaben in Celsiusgraden; die Schmelz- und Siedepunkte sind nicht   kolTi-    giert.
EMI1.1     




   Beispiel I    4-Hydroxy-4-( 1 -methyl-2-oxo-3 -pyrrolidinyl)-    piperidin a)   l-Benzyl-4-hydroxy-4-(1-methyl-2-oxo-3-pyrro-    lidinyl)-piperidin
1,4 g Lithium werden in 300 ml flüssigem Ammoniak in Gegenwart von Eisen-III-nitrat zu Lithium amid umgesetzt. Diese Lithiumamidsuspension wird darauf tropfenweise mit 20,8 g   1-Methyl-2-pyrrolldon    versetzt. Man rührt das Gemisch während 30 Minuten bei der Temperatur des flüssigen Ammoniaks und tropft darauf langsam 18,9 g 1-Benzyl-4-piperidon zu. Nach zweistündigem Rühren lässt man den Ammoniak verdampfen und versetzt den Rückstand mit 500 ml abs.



  Äther. Man rührt während 41/2 Stunden bei Siedetemperatur und zersetzt darauf das Reaktionsgemisch unter Eiskühlung mit 100 ml 10 % iger Ammoniumchloridlösung. Die Ätherphase wird zweimal mit Wasser gewaschen, über Natriumsulfat getrocknet und eingedampft. Man destilliert den Rückstand unter stark vermindertem Druck, wobei das reine    l-Benzyl-4-hydroxy-4-( l-methyl-2-oxo-3-    pyrrolidinyl)-piperidin bei   155-1700/10-1    mm Hg übergeht (Temperatur im Luftbad gemessen).

   b)   4-Hydroxy-4-(1-methyl-2-oxo-3-pyrrolidinyl)-       piperidm   
11,8   g 1 - Benzyl -4 - hydroxy-4-(t-methyl-2-oxo-3-    pyrrolidinyl)-piperidin werden in 150 ml Eisessig gelöst und in Gegenwart von 2,5 g eines   Palladiumkata-    lysators   (10 %    auf Kohle) bei einem Anfangsdruck von 5 atü und einer Temperatur von 500 hydriert. Die für die Debenzylierung berechnete Menge Wasserstoff ist nach 4 Stunden absorbiert. Man filtriert vom Katalysator ab, dampft das Filtrat zur Trockne ein und nimmt den Rückstand in   40% der    wässriger Kaliumcarbonatlösung und Chloroform auf. Man sättigt die wässrige Phase annähernd mit festem Kaliumcarbonat, extrahiert mehrmals mit Chloroform und dampft die über Natriumsulfat getrockneten Extrakte ein.

   Der Rückstand wird unter stark vermindertem Druck destilliert, wobei das reine   4-Hydroxy-4-( 1 -methyl-2-oxo-    3-pyrrolidinyl)-piperidin bei   120-1400/10-4    mm Hg übergeht (Temperatur im Luftbad gemessen).



   Beispiel 2    4-Hydroxy-4-( 1 -äthyl-2-oxo-3 -pyrrolidinyl)-    piperidin a)   l-Benzyl-4-hydroxy-4-(1 -äthyl-2-oxo-3 -pyrrolidinyl)-    piperidin
1,4 g Lithium werden in 400 ml flüssigem Ammoniak in Gegenwart von Eisen-III-nitrat zu Lithiumamid umgesetzt. Diese Lithiumamidsuspension wird darauf tropfenweise mit 44,3 g 1-Äthyl-2-pyrrolidon versetzt. Man rührt das Gemisch während 30 Minuten bei der Temperatur des flüssigen Ammoniaks und tropft darauf langsam 18,9 g 1-Benzyl-4-piperidon zu. Nach zweistündigem Rühren lässt man den Ammoniak verdampfen und versetzt den Rückstand mit 500   ml    abs.



  Äther. Man rührt während 41/2 Stunden bei Siedetemperatur und zersetzt darauf das Reaktionsgemisch unter Eiskühlung mit 100 ml 10% iger Ammonium  chloridlösung.    Die Ätherphase wird zweimal mit Wasser gewaschen, über Natriumsulfat getrocknet und eingedampft. Man destilliert den Rückstand unter stark vermindertem Druck, wobei das 1-Benzyl-4-hydroxy-4  (1-äthyl-2-oxo-3-pyrrolldinyl) - piperidin    erhalten wird, das ohne weitere Reinigung in der nächsten Stufe weiterverwendet wird.

   b)   4-Hydroxy-4-( 1 -äthyl-2-oxo-3 pyrrolidinyl)-    piperidin
11,8 g   l-Benzyl-4-hydroxy-4- (1-äthyl-2-oxo-3-    pyrrolidinyl)-piperidin werden in 150 ml Eisessig gelöst und in Gegenwart von 2,5 g eines Palladiumkatalysators   (10%    auf Kohle) bei einem Anfangsdruck von 5 atü und einer Temperatur von 500 hydriert. Die für die Debenzylierung berechnete Menge Wasserstoff ist nach 4 Stunden absorbiert. Man filtriert vom Katalysator ab, dampft das Filtrat zur Trockne ein und nimmt den Rückstand in   40% iger    wässriger Kaliumkarbonatlösung und Chloroform auf. Man sättigt die wässrige Phase annähernd mit festem Kaliumkarbonat, extrahiert mehrmals mit Chloroform und dampft die über Natriumsulfat getrockneten Extrakte ein.

   Der Rückstand wird unter stark vermindertem Druck destilliert, wobei das reine   4-Hydroxy-4-( 1 -äthyl-2-oxo-3 -pyrroli-    dinyl)-piperidin bei   170-1900/0,08    mm Hg übergeht (Temperatur im Luftbad gemessen).



  



  Process for the production of new piperidine derivatives
The present invention relates to a process for the preparation of new piperidine derivatives of the formula I, in which R stands for a lower alkyl group.



   According to the invention, the compounds of the formula I are prepared by reacting compounds of the formula II, in which R has the above meaning, in the presence of an alkali metal amide in a solvent which is inert under the reaction conditions, with l-benzyl-4-piperidone and the resulting condensation product is reacted with the benzyl group split off by hydrogenolysis.



   In the process according to the invention, the alkali metal amide is preferably lithium amide, and the solvent which is inert under the reaction conditions, e.g. B. liquid ammonia, absolute ether, absolute dioxane or mixtures thereof are used.



   The process is carried out, for example, by slowly adding the compound of the formula II to a suspension of lithium amide in liquid ammonia and, after stirring for about 30 minutes, adding l-benzyl-4piperidone dropwise. After stirring for about 2 hours, the ammonia is allowed to evaporate, and abs is added to the residue. Ether and stir the mixture to complete the reaction for 4-5 hours. at the boiling point of the solvent. The reaction mixture is then decomposed while cooling with aqueous ammonium chloride solution; the ether phase is washed with water, dried and evaporated.



   For the hydrogenolytic cleavage of the benzyl group, the compound obtained as a residue, e.g. B. in glacial acetic acid, hydrogenated over a palladium catalyst at about 500 and about 5 atmospheres in a pressure vessel.



   The compounds of the formula I prepared according to the invention have not yet been described. They are intermediate products for valuable drugs.



   In the following examples, which illustrate the implementation of the process but are not intended to restrict the scope of the present invention in any way, all temperatures are given in degrees Celsius; the melting and boiling points are not colored.
EMI1.1




   Example I 4-Hydroxy-4- (1-methyl-2-oxo-3-pyrrolidinyl) piperidine a) l-Benzyl-4-hydroxy-4- (1-methyl-2-oxo-3-pyrrolidinyl) -piperidine
1.4 g of lithium are converted into lithium amide in 300 ml of liquid ammonia in the presence of iron (III) nitrate. This lithium amide suspension is then treated dropwise with 20.8 g of 1-methyl-2-pyrrolldon. The mixture is stirred for 30 minutes at the temperature of the liquid ammonia and 18.9 g of 1-benzyl-4-piperidone are slowly added dropwise. After two hours of stirring, the ammonia is allowed to evaporate and 500 ml of abs are added to the residue.



  Ether. The mixture is stirred for 41/2 hours at boiling temperature and the reaction mixture is then decomposed with 100 ml of 10% strength ammonium chloride solution while cooling with ice. The ether phase is washed twice with water, dried over sodium sulfate and evaporated. The residue is distilled under greatly reduced pressure, the pure l-benzyl-4-hydroxy-4- (l-methyl-2-oxo-3-pyrrolidinyl) piperidine passing over at 155-1700 / 10-1 mm Hg (temperature measured in an air bath).

   b) 4-Hydroxy-4- (1-methyl-2-oxo-3-pyrrolidinyl) piperidm
11.8 g of 1-benzyl -4-hydroxy-4- (t-methyl-2-oxo-3-pyrrolidinyl) piperidine are dissolved in 150 ml of glacial acetic acid and in the presence of 2.5 g of a palladium catalyst (10% on charcoal) at an initial pressure of 5 atm and a temperature of 500 hydrogenated. The amount of hydrogen calculated for the debenzylation is absorbed after 4 hours. The catalyst is filtered off, the filtrate is evaporated to dryness and the residue is taken up in 40% of the aqueous potassium carbonate solution and chloroform. The aqueous phase is approximately saturated with solid potassium carbonate, extracted several times with chloroform and the extracts dried over sodium sulfate are evaporated.

   The residue is distilled under greatly reduced pressure, the pure 4-hydroxy-4- (1-methyl-2-oxo-3-pyrrolidinyl) piperidine passing over at 120-1400 / 10-4 mm Hg (temperature measured in an air bath) .



   Example 2 4-Hydroxy-4- (1-ethyl-2-oxo-3-pyrrolidinyl) -piperidine a) 1-Benzyl-4-hydroxy-4- (1-ethyl-2-oxo-3-pyrrolidinyl) -piperidine
1.4 g of lithium are converted to lithium amide in 400 ml of liquid ammonia in the presence of iron (III) nitrate. This lithium amide suspension is then treated dropwise with 44.3 g of 1-ethyl-2-pyrrolidone. The mixture is stirred for 30 minutes at the temperature of the liquid ammonia and 18.9 g of 1-benzyl-4-piperidone are slowly added dropwise. After two hours of stirring, the ammonia is allowed to evaporate and 500 ml of abs are added to the residue.



  Ether. The mixture is stirred for 41/2 hours at boiling temperature and the reaction mixture is then decomposed with 100 ml of 10% ammonium chloride solution while cooling with ice. The ether phase is washed twice with water, dried over sodium sulfate and evaporated. The residue is distilled under greatly reduced pressure, 1-benzyl-4-hydroxy-4 (1-ethyl-2-oxo-3-pyrrole-dinyl) piperidine being obtained, which is used in the next stage without further purification.

   b) 4-Hydroxy-4- (1-ethyl-2-oxo-3-pyrrolidinyl) piperidine
11.8 g of l-benzyl-4-hydroxy-4- (1-ethyl-2-oxo-3-pyrrolidinyl) piperidine are dissolved in 150 ml of glacial acetic acid and in the presence of 2.5 g of a palladium catalyst (10% on carbon ) hydrogenated at an initial pressure of 5 atm and a temperature of 500. The amount of hydrogen calculated for the debenzylation is absorbed after 4 hours. The catalyst is filtered off, the filtrate is evaporated to dryness and the residue is taken up in 40% strength aqueous potassium carbonate solution and chloroform. The aqueous phase is approximately saturated with solid potassium carbonate, extracted several times with chloroform and the extracts, dried over sodium sulfate, are evaporated.

   The residue is distilled under greatly reduced pressure, the pure 4-hydroxy-4- (1-ethyl-2-oxo-3-pyrrolidinyl) piperidine passing over at 170-1900 / 0.08 mm Hg (temperature in an air bath measured).

 

Claims (1)

Beispiel 3 4-Hydroxy-4-( 1 -isopropyl-2-oxo-3 -pyrrolidinyl) piperidin 4-Hydroxy-4-( 1 -isopropyl-2-oxo-3 -pyrrolidinyl)- piperidin wird analog Beispiel 2 hergestellt. Sdp. 159-160 / 0,1 mm Hg PATENTANSPRUCH Verfahren zur Herstellung von neuen Piperidin Derivaten der Formel I, worin R für eine niedere Alkylgruppe steht, dadurch gekennzeichnet, dass man Verbindungen der Formel II, worin R die obige Bedeutung besitzt, in Gegenwart eines Alkalimetallamids in einem unter den Reaktionsbedingungen inerten Lösungsmittel mit 1-Benzyl-4-piperidon umsetzt und von dem erhaltenen Kondensationsprodukt die Benzylgruppe hydrogenolytisch abspaltet. Example 3 4-Hydroxy-4- (1-isopropyl-2-oxo-3-pyrrolidinyl) piperidine 4-Hydroxy-4- (1-isopropyl-2-oxo-3-pyrrolidinyl) piperidine is prepared analogously to Example 2. Bp 159-160 / 0.1 mm Hg PATENT CLAIM Process for the preparation of new piperidine derivatives of the formula I, in which R stands for a lower alkyl group, characterized in that compounds of the formula II, in which R has the above meaning, in the presence of an alkali metal amide in a solvent which is inert under the reaction conditions with 1- Reacts benzyl-4-piperidone and splits off the benzyl group hydrogenolytically from the condensation product obtained.
CH53669A 1966-05-10 1966-05-10 Process for the production of new piperidine derivatives CH478820A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH53669A CH478820A (en) 1966-05-10 1966-05-10 Process for the production of new piperidine derivatives

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH53669A CH478820A (en) 1966-05-10 1966-05-10 Process for the production of new piperidine derivatives
CH679966A CH480363A (en) 1966-05-10 1966-05-10 Process for the preparation of new phenothiazine derivatives
CH708166A CH476757A (en) 1966-05-16 1966-05-16 Process for the preparation of new phenothiazine derivatives
CH1301666 1966-09-08
CH1301466 1966-09-08
CH337167A CH504467A (en) 1967-03-08 1967-03-08 (A) Cmpds. (I) R1=H, halogen, CF3, CN, (1-4C) alkanoyl, (1-4C) alkoxy or (1-4C) alkyl-S-. R2=H or Me R3 and R4=(1-4C) alkyl, or together with
CH337267 1967-03-08
CH337067 1967-03-08

Publications (1)

Publication Number Publication Date
CH478820A true CH478820A (en) 1969-09-30

Family

ID=27570346

Family Applications (1)

Application Number Title Priority Date Filing Date
CH53669A CH478820A (en) 1966-05-10 1966-05-10 Process for the production of new piperidine derivatives

Country Status (1)

Country Link
CH (1) CH478820A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038003A2 (en) * 1980-04-09 1981-10-21 E.I. Du Pont De Nemours And Company Antidepressant pyrrolylpiperidines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038003A2 (en) * 1980-04-09 1981-10-21 E.I. Du Pont De Nemours And Company Antidepressant pyrrolylpiperidines
EP0038003A3 (en) * 1980-04-09 1981-12-16 E.I. Du Pont De Nemours And Company Antidepressant pyrrolylpiperidines

Similar Documents

Publication Publication Date Title
DE2229223C3 (en) 2-Nitro-S-imidazole derivatives and processes for their preparation
DE2519943C3 (en) Process for the preparation of amides of abietic acid, dehydro-, dihydro- or tetrahydroabietic acid
DE19600034C2 (en) 1,1,2-Trisubstituted cyclopropane compounds, process for their preparation and dihydroxyethyl-substituted 1-amino-cyclopropane-1-carboxylic acid
CH478820A (en) Process for the production of new piperidine derivatives
CH642370A5 (en) Process for the preparation of imidazo[2,1-a]isoindoles
CH459219A (en) Process for the production of 6- and 7-membered A-ring lactams of the androstane series
DE2065311C3 (en) v- (4-Hydroxy-4-phenylpiperidino) -2-amino-4fluorobutyrophenones, processes for their preparation and pharmaceuticals containing these compounds
AT229874B (en) Process for the preparation of new (5- or 6) -alkyl- and 5, 6-dialkyl-3-alkoxy-pyrazines
AT238174B (en) Process for the preparation of N- (2,3-dimethylphenyl) anthranilic acid and its salts
AT226228B (en) Process for the production of new sulfonamides
CH535236A (en) 6-nor-lysergic acid derivs - with pharmacological activity
AT308754B (en) Process for the preparation of benzodiazepine derivatives and acid addition salts thereof
DE828102C (en) Process for the preparation of 3-phenaceturyl-5-dimethyl-thiazolidine-4-carboxylic acid
DE1900948C (en) Cis- and trans-2-methyl-5- (3, 4, S-trimethoxybenzamidoJ-decahydroisoquinoline
DE825548C (en) Process for the preparation of new diquartar salts of pyrimidylaminocinnolines
DE2166258C3 (en) Amino alcohols, processes for their production and medicinal preparations containing these compounds
AT204554B (en) Process for the preparation of N-alkyl-α-piperidinecarboxylic acid anilides
DE812314C (en) Process for the preparation of 1,2-iminocyclohexanes
AT208867B (en) Process for the preparation of new substituted heterocyclic acid hydrazides
AT212301B (en) Process for the preparation of new aniline disulphonic acid chloride derivatives
AT244333B (en) Process for the production of new pyrrole derivatives
AT215996B (en) Process for the preparation of new pyridine derivatives
AT212328B (en) Process for the production of new urea inclusion compounds
DE3135728A1 (en) Process for preparing apovincamine acid esters
DE2361493A1 (en) N-HALOGENALKYL DERIVATIVES OF CYCLIC UREID

Legal Events

Date Code Title Description
PL Patent ceased